Feature

AI vs superbugs: Is the future of antibiotics here?

There’s no escaping the foreboding headlines that predict the end of the world as we know it, thanks to the severely damaging side effects of artificial intelligence on everything from the environment to creative industries. However, amongst all this doom and gloom, a rare piece of positive AI-related news recently caught my attention: a medical breakthrough that could be truly game-changing...

02/09/2025 15:30:05

Font size:

Back in March, I discussed the NHS’s initiative to evaluate
AI’s ability to speed up breast cancer diagnosis.

Now, another major development
has taken place in the medical sector: MIT scientists have used
artificial intelligence to develop potentially revolutionary antibiotics that could fight drug-resistant bacteria,
and treat MRSA infections and gonorrhoea.

Read the full article in DPA's September 2025 issue

Written By Sophia Bell

Sophia Bell is the Group Editor of DPA, Connectivity, and PBSI. She joined the team in 2020 as Assistant Editor after achieving a First-Class Honours BA in English Literature and Film Studies from the University of East Anglia. In her current role, she leads the editorial strategy, driving digital growth and ensuring each title continues to deliver trusted, relevant insight for engineering and manufacturing professionals.